Understanding how ZSWIM8 affects blood cell production and platelet formation
Characterization of the role of ZSWIM8 and target-directed microRNA degradation in hematopoiesis
This study is looking at how a protein called ZSWIM8 affects the production of platelets from blood stem cells, which could help us find new ways to treat people with low platelet counts, like those with thrombocytopenia.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10996325 on NIH RePORTER |
What this research studies
This research investigates the role of ZSWIM8, a protein that influences the degradation of specific microRNAs, in the production of blood cells, particularly platelets. By studying how ZSWIM8 affects the differentiation of megakaryocytes from hematopoietic stem cells, the research aims to uncover fundamental processes that could lead to new treatments for thrombocytopenia, a condition characterized by low platelet counts. The approach involves using mouse models to observe the effects of ZSWIM8 knockout on blood cell development and microRNA expression. This could provide insights into potential therapeutic strategies for patients suffering from blood disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with thrombocytopenia or related hematologic conditions who may benefit from improved understanding and treatment options.
Not a fit: Patients with conditions unrelated to blood cell production or those who do not have thrombocytopenia may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for patients with thrombocytopenia, improving their platelet counts and reducing the risk of life-threatening bleeding.
How similar studies have performed: While the specific role of ZSWIM8 in hematopoiesis is being explored, similar research on microRNA mechanisms in blood cell differentiation has shown promising results, indicating potential for success.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Elcavage, Lara — Harvard Medical School
- Study coordinator: Elcavage, Lara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.